Psychopharmacology and Psychiatry Updates

En podkast av Psychopharmacology Institute

Kategorier:

243 Episoder

  1. Mastering Clozapine: Adverse Effect Management

    Publisert: 6.5.2024
  2. Preventing Depression and Anxiety Relapse in Youth

    Publisert: 1.5.2024
  3. Charting the Clozapine Course: Titration and Monitoring

    Publisert: 26.4.2024
  4. Smoking and Psychosis: Insights from the PATH Study

    Publisert: 21.4.2024
  5. Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia

    Publisert: 16.4.2024
  6. Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry

    Publisert: 11.4.2024
  7. Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice

    Publisert: 6.4.2024
  8. Zuranolone: A New Dawn for Postpartum Depression Treatment

    Publisert: 1.4.2024
  9. Micronutrients for Psychiatric Disorders: Optimizing Clinical Use

    Publisert: 27.3.2024
  10. Olanzapine in Pregnancy: Examining the Risks

    Publisert: 22.3.2024
  11. Understanding Safety Risks of Broad-Spectrum Micronutrients

    Publisert: 17.3.2024
  12. The Role of Inflammation in Delirium: Can NSAIDs Help?

    Publisert: 12.3.2024
  13. Beyond Medication: Exploring Nutritional Psychiatry

    Publisert: 7.3.2024
  14. Age Impact on Antidepressant Outcomes

    Publisert: 2.3.2024
  15. Dealing With Delirium in Patients With Advanced Cancer

    Publisert: 26.2.2024
  16. Rechallenging Clozapine: A Look at Colony Stimulating Factors

    Publisert: 21.2.2024
  17. Managing Anxiety in Patients With Cancer

    Publisert: 16.2.2024
  18. Managing Antidepressant Side Effects in Youth

    Publisert: 11.2.2024
  19. Depressed Patient With Cancer? Here’s How to Treat

    Publisert: 6.2.2024
  20. Brexanolone: A Quick Fix for Postpartum Depression and Anxiety?

    Publisert: 1.2.2024

3 / 13

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site